ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,645.93
1.20%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Mast Therapeutics, Inc. (ANX)

  7. Mast Therapeutics, Inc. (ANX) Noticias

ANX

Adventrx (ANX)

Mast Therapeutics, Inc.
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:ANX
FechaHoraFuenteTítuloSímboloCompañía
27/04/201502:21Analyst Ratings NetworkRoth Capital Initiates Coverage on Mast Therapeutics (ANX)AMEX:ANXMast Therapeutics, Inc.
16/06/201407:00PR Newswire (US)Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC TrialAMEX:ANXMast Therapeutics, Inc.
14/04/201407:00PR Newswire (US)Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell DiseaseAMEX:ANXMast Therapeutics, Inc.
10/02/201407:00PR Newswire (US)Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.AMEX:ANXMast Therapeutics, Inc.
03/09/201307:00PR Newswire (US)Mast Therapeutics To Present At The Rodman & Renshaw 15th Annual Healthcare Conference On September 10AMEX:ANXMast Therapeutics, Inc.
11/03/201307:00PR Newswire (US)ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"AMEX:ANXMast Therapeutics, Inc.
01/03/201315:11Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANXMast Therapeutics, Inc.
28/02/201316:15PR Newswire (US)ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"AMEX:ANXMast Therapeutics, Inc.
28/02/201315:01PR Newswire (US)Adventrx To Develop ANX-188 For Complications Of Arterial DiseaseAMEX:ANXMast Therapeutics, Inc.
26/02/201307:00PR Newswire (US)ADVENTRX Reviews Data Supporting Development Of ANX-188 In New IndicationsAMEX:ANXMast Therapeutics, Inc.
25/02/201307:00PR Newswire (US)ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4AMEX:ANXMast Therapeutics, Inc.
11/02/201307:00PR Newswire (US)ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
05/02/201307:00PR Newswire (US)ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12AMEX:ANXMast Therapeutics, Inc.
30/01/201306:00PR Newswire (US)ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188AMEX:ANXMast Therapeutics, Inc.
18/01/201317:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
10/01/201308:55Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ANXMast Therapeutics, Inc.
10/01/201308:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:ANXMast Therapeutics, Inc.
04/01/201307:00PR Newswire (US)ADVENTRX Announces Appointment of Chief Financial OfficerAMEX:ANXMast Therapeutics, Inc.
03/01/201315:40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
03/01/201305:07Edgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
02/01/201307:00PR Newswire (US)ADVENTRX To Present At The 6th Annual OneMedForum Emerging Company Finance Conference On January 8AMEX:ANXMast Therapeutics, Inc.
19/12/201215:19Edgar (US Regulatory)Other Filing (40-app/a)AMEX:ANXMast Therapeutics, Inc.
19/12/201207:00PR Newswire (US)ADVENTRX To Initiate Phase 3 Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
03/12/201207:30PR Newswire (US)ADVENTRX Announces Launch Of New Corporate WebsiteAMEX:ANXMast Therapeutics, Inc.
05/11/201216:03Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ANXMast Therapeutics, Inc.
05/11/201207:00PR Newswire (US)ADVENTRX Reports Third Quarter 2012 Financial ResultsAMEX:ANXMast Therapeutics, Inc.
25/10/201215:05PR Newswire (US)ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
23/10/201207:30PR Newswire (US)ADVENTRX Announces Conference Call To Review Protocol For Phase 3 Clinical Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
02/10/201207:00PR Newswire (US)ADVENTRX Engages Theradex Systems, Inc. to Manage Phase 3 Clinical Study of ANX-188AMEX:ANXMast Therapeutics, Inc.
07/09/201211:58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ANXMast Therapeutics, Inc.
 Showing the most relevant articles for your search:AMEX:ANX

Su Consulta Reciente

FX
EURMXN
Euro vs MXN
CCOM
SILVER
SILVER
NYSE
VZ
Verizon Communications
USI
USTECH100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
CCOM
US500
US 500
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
COIN
SOLUSD
Solana
CCOM
OILBRENT
Brent Oil
NASDAQ
AMZN
Amazon.com
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados